Protective effect of oleuropein on the brain tissue in D-Galactose-induced aging in rat model

Mol Biol Rep. 2024 Dec 20;52(1):67. doi: 10.1007/s11033-024-10165-9.

Abstract

Background: Oleuropein (OLE) has the potential to reduce oxidative stress and inflammation. So, in the present investigation, we explored the protective effect of OLE on brain aging induced by d-galactose (D-Gal) in a rat model.

Methods and results: 40 Wister male adult rats were categorized into 5 groups. Group 1 received normal saline; group 2 was given 100 mg/kg of D-Gal intraperitoneally (IP). The rats in groups 3 to 5 were given D-Gal (100 mg/kg, IP) along with different doses of OLE (20, 40, and 80 mg/kg, respectively) orally. All administrations were performed daily for 8 weeks. 24 h after last treatment motor activity and memory impairment were evaluated. Then, the rats were euthanized and brain samples were collected for evaluating the levels of malondialdehyde (MDA), Brain-Derived Neurotrophic Factor (BDNF), protein carbonyl (PC), glutathione (GSH), glutathione peroxidase (GPX), catalase (CAT), Superoxide dismutase (SOD), Tumor necrosis factor alpha (TNF-α), interleukin 1 beta ( IL-1β), as well as Sirtuin 1 (SIRT1) and peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1) gene expression. The results showed that D-Gal significantly reduced motor activity and memory performance (P < 0.05). It also significantly reduced the GPX, CAT and SOD activities, GSH and BDNF levels as well as SIRT1 and PGC1 expression, and, significantly increased PC, MDA TNF-α and IL-1β levels in the brain tissue (P < 0.05). Administration of OLE restored all of the above parameters close to control group.

Conclusion: The findings demonstrated that OLE, through its antioxidant and anti-inflammatory properties, improved motor activity, memory impairment, and age-related neurological dysfunction.

Keywords: Brain tissue; D-galactose; Oleuropein; Oxidative stress.

MeSH terms

  • Aging* / drug effects
  • Animals
  • Antioxidants / metabolism
  • Antioxidants / pharmacology
  • Brain* / drug effects
  • Brain* / metabolism
  • Brain-Derived Neurotrophic Factor / genetics
  • Brain-Derived Neurotrophic Factor / metabolism
  • Catalase / metabolism
  • Disease Models, Animal
  • Galactose* / pharmacology
  • Glutathione / metabolism
  • Glutathione Peroxidase / metabolism
  • Interleukin-1beta / genetics
  • Interleukin-1beta / metabolism
  • Iridoid Glucosides* / pharmacology
  • Iridoids / pharmacology
  • Male
  • Malondialdehyde / metabolism
  • Memory Disorders / drug therapy
  • Memory Disorders / metabolism
  • Neuroprotective Agents / pharmacology
  • Oxidative Stress* / drug effects
  • Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha / genetics
  • Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha / metabolism
  • Rats
  • Rats, Wistar*
  • Sirtuin 1* / genetics
  • Sirtuin 1* / metabolism
  • Superoxide Dismutase / metabolism
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Iridoid Glucosides
  • Galactose
  • oleuropein
  • Sirtuin 1
  • Antioxidants
  • Superoxide Dismutase
  • Malondialdehyde
  • Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
  • Glutathione Peroxidase
  • Iridoids
  • Brain-Derived Neurotrophic Factor
  • Tumor Necrosis Factor-alpha
  • Glutathione
  • Neuroprotective Agents
  • Catalase
  • Interleukin-1beta
  • Ppargc1a protein, rat